10,000 liver patients enrolled in landmark Long-Term study
NCT ID NCT03267615
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 10,000 people with advanced chronic liver disease at Vienna General Hospital. Researchers will track their health over time, collect blood, urine, and tissue samples, and record complications like bleeding or liver failure. The goal is to better understand how cirrhosis progresses and what factors affect survival without a transplant.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better predict and manage liver cirrhosis complications.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly test new therapies. Results may take years to emerge.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED CHRONIC LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medical University of Vienna
RECRUITINGVienna, 1090, Austria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- Can everyday drugs shield the liver from Cirrhosis's worst threats?
- A new procedure may offer relief for Cirrhosis-Related fluid buildup
- Can extra doses of an old drug reverse liver scarring?
- Can liver damage predict how drugs behave?
- Melatonin may ease sleep and brain fog in liver disease — a trial puts it to the test